The Latest Trading Price of Shri Ahimsa Naturals Ltd is ₹ 240.2 as of 20 Mar 15:30
. The P/E Ratio of Shri Ahimsa Naturals Ltd is 0 as of March 2023
.The P/E Ratio of Vadivarhe Speciality Chemicals Ltd is 0 as of March 2023
. The Market Cap of Shri Ahimsa Naturals Ltd is ₹ 0 crore as of March 2023
.The Market Cap of Vadivarhe Speciality Chemicals Ltd is ₹ 0 crore as of March 2023
. The Dividend Payout of Shri Ahimsa Naturals Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Vadivarhe Speciality Chemicals Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .
About Shri Ahimsa Naturals Ltd
Ahimsa Naturals Limited was originally incorporated in the name and style of 'Ahimsa Mines and Minerals Private Limited' with the Registrar of Companies, Jaipur, on October 17, 1990.
Further, the name was changed to 'Shri Ahimsa Mines and Minerals Private Limited', and a fresh Certificate of Incorporation dated July 14, 1992.
Subsequently, the Company status changed to a Public Company and the name of the Company was changed to 'Shri Ahimsa Mines and Minerals Limited' dated August 19, 1992 issued by the Registrar of Companies, Jaipur.
Thereafter, Company name was changed to 'Shri Ahimsa Naturals Limited' and a fresh Certificate of Incorporation dated April 25, 2023 was issued by the RoC, Jaipur.
The Company commenced its operations in 1990 and presently engaged in the extraction, manufacturing, of Caffeine Anhydrous Natural, Green Coffee Bean Extracts (GCE) and Crude Caffeine along with trading of other herbal extracts.
About Vadivarhe Speciality Chemicals Ltd
Vadivarhe Speciality Chemicals Limited (VSCL) was incorporated on February 23, 2009 and prior to incorporation of the Company, Fem Care Pharma Ltd was promoted by the promoter Mr. Sunil Haripant Pophale which was later taken over by Dabur India Limited in 2009.
Mr. Sunil Haripant Pophale sold his stake in Fem Care Pharma Ltd to Dabur India Limited and as per the terms and condition of the Division Transfer Agreement dated May 07, 2009 the Speciality Chemical Division of Fem Care Pharma Limited was transferred to the Company as a going concern.
After the above transfer, the Company is running the Speciality Chemical Division under the leadership of the Promoter, Mr. Sunil Haripant Pophale.
In 2010, the Company started API manufacturing.
In January-2011, Company started a Trading Business of Nutraceutical / Health Supplementary Products which was later discontinued effective from April 01, 2013.
FAQs for the comparison of Shri Ahimsa Naturals Ltd and Vadivarhe Speciality Chemicals Ltd
Which company has a larger market capitalization, Shri Ahimsa Naturals Ltd or Vadivarhe Speciality Chemicals Ltd?
Market cap of Shri Ahimsa Naturals Ltd is 562 Cr while Market cap of Vadivarhe Speciality Chemicals Ltd is 28 Cr
What are the key factors driving the stock performance of Shri Ahimsa Naturals Ltd and Vadivarhe Speciality Chemicals Ltd?
The stock performance of Shri Ahimsa Naturals Ltd and Vadivarhe Speciality Chemicals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.
What are the recent stock price for Shri Ahimsa Naturals Ltd and Vadivarhe Speciality Chemicals Ltd?
As of March 23, 2026, the Shri Ahimsa Naturals Ltd stock price is INR ₹240.2. On the other hand, Vadivarhe Speciality Chemicals Ltd stock price is INR ₹22.25.
How do dividend payouts of Shri Ahimsa Naturals Ltd and Vadivarhe Speciality Chemicals Ltd compare?
To compare the dividend payouts of Shri Ahimsa Naturals Ltd and Vadivarhe Speciality Chemicals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.